Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

Durham, NC, USA

Ten63 Therapeutics

Life Sciences

Delivers academic-driven research and education programs in the nexus of sustainability and business.

Duke University

Duke Capital Partners

Companies in the Duke Capital Partners portfolio are looking for talented, ambitious people to join their teams.

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Duke University Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Duke University network as they come up.

You can always update this information later.

Welcome to the Duke University talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Duke University company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Jobs at Portfolio Companies